Yuyu Pharma, Inc. (KRX:000220)
4,555.00
+10.00 (0.22%)
Feb 21, 2025, 9:00 AM KST
Yuyu Pharma Revenue
Yuyu Pharma had revenue of 33.60B KRW in the quarter ending September 30, 2024, a decrease of -1.44%. This brings the company's revenue in the last twelve months to 134.79B, down -1.86% year-over-year. In the year 2023, Yuyu Pharma had annual revenue of 137.21B, down -1.20%.
Revenue (ttm)
134.79B
Revenue Growth
-1.86%
P/S Ratio
0.55
Revenue / Employee
532.77M
Employees
253
Market Cap
73.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 137.21B | -1.67B | -1.20% |
Dec 31, 2022 | 138.88B | 23.23B | 20.08% |
Dec 31, 2021 | 115.66B | 17.54B | 17.87% |
Dec 31, 2020 | 98.12B | 7.24B | 7.97% |
Dec 31, 2019 | 90.88B | 7.78B | 9.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |